BEYOND AIR INC. - COMMON STOCK

0,3503

21-февраля-25 16:45:00

15 мин. задержка

Акции

-0,0053

-1,49%

Сегодняшний диапазон

0,3416 - 0,3750

ISIN

N/A

Источник

NASDAQ

Beyond Air® To Participate in the Roth MKM 2023 Healthcare Opportunities Conference

02 окт 2023 16:05:00 Источник Nasdaq GlobeNewswire
Beyond Cancer™ to Present Initial Clinical Data for Ultra-High Concentration Nitric Oxide Therapy at the 2023 SITC Annual Meeting

27 сен 2023 09:00:00 Источник Nasdaq GlobeNewswire
Beyond Air® Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder

18 сен 2023 16:05:00 Источник Nasdaq GlobeNewswire
Beyond Air® To Participate in the 2023 Cantor Global Healthcare Conference

06 сен 2023 07:00:00 Источник Nasdaq GlobeNewswire
Beyond Air® Reports Financial Results for First Quarter of Fiscal Year 2024

10 авг 2023 16:05:01 Источник Nasdaq GlobeNewswire
Beyond Air® Announces Positive Preclinical Data on Role of Nitric Oxide in Autism Spectrum Disorder (ASD)

07 авг 2023 16:05:00 Источник Nasdaq GlobeNewswire
Beyond Air® To Participate in BTIG’s 2023 Virtual Biotechnology Conference

01 авг 2023 16:05:00 Источник Nasdaq GlobeNewswire
Beyond Air® Reports Financial Results for Fourth Quarter and Fiscal Year-End 2023

22 июн 2023 16:05:00 Источник Nasdaq GlobeNewswire
Beyond Air® Secures up to $40 Million Debt Financing

15 июн 2023 16:10:00 Источник Nasdaq GlobeNewswire
Beyond Air® Licenses Commercial Rights to Selective Neuronal Nitric Oxide Synthase (nNOS) Inhibitors for the Treatment of Autism Spectrum Disorder from Hebrew University of Jerusalem

15 июн 2023 16:05:00 Источник Nasdaq GlobeNewswire
Beyond Air® Schedules Fiscal Year End 2023 Financial Results Conference Call and Webcast

16 май 2023 16:05:00 Источник Nasdaq GlobeNewswire
Beyond Cancer™ Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the American Association for Cancer Research (AACR) 2023 Annual Meeting

19 апр 2023 09:00:02 Источник Nasdaq GlobeNewswire
Beyond Air® Appoints Jeff Myers, M.D. Ph.D. as Chief Medical Officer

23 мар 2023 16:05:00 Источник Nasdaq GlobeNewswire
Beyond Cancer™ to Present Two Posters for Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2023 AACR Annual Meeting

14 мар 2023 16:35:00 Источник Nasdaq GlobeNewswire
Beyond Air® Announces Participation at Two Upcoming Investor Conferences in March 2023

22 фев 2023 07:00:01 Источник Nasdaq GlobeNewswire
Beyond Air® Reports Financial Results for the Third Quarter of Fiscal Year 2023

09 фев 2023 16:05:00 Источник Nasdaq GlobeNewswire
Beyond Cancer® Appoints Gavin Choy, PharmD as Chief Operating Officer

30 янв 2023 07:00:00 Источник Nasdaq GlobeNewswire
Beyond Cancer® Announces Sponsored Research Agreement with Stanford and Appointment of Frederick M. Dirbas, MD and Mark D. Pegram, MD to Scientific Advisory Board

24 янв 2023 16:05:00 Источник Nasdaq GlobeNewswire
Beyond Air® Schedules Third Fiscal Quarter 2023 Financial Results Conference Call and Webcast

17 янв 2023 16:05:00 Источник Nasdaq GlobeNewswire
Beyond Cancer® Publishes Pre-Clinical Data in Cancer Cell International Demonstrating Its Tumor Ablation Method Utilizing Ultra-High Concentration Nitric Oxide (UNO) Induced a Systemic Response that Prevents Metastases

13 дек 2022 09:25:14 Источник Nasdaq GlobeNewswire

<<
<
1
2
3
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.